Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
Biochimie
|
April 3, 2007
cyclicAMP and glucocorticoid responsiveness of the rat carbamoylphosphate synthetase gene requires the interplay of upstream regulatory units
Onard J L M Schoneveld, Maarten Hoogenkamp, Jan M Stallen, et al.
Biochimie
|
November 6, 2012
Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
Frank G Schaap, Andreas E Kremer, Wouter H Lamers, et al.
Endocrinology
|
February 1, 1996
All-trans-4-oxo-retinoic acid: a potent inducer of in vivo proliferation of growth-arrested A spermatogonia in the vitamin A-deficient mouse testis
I C Gaemers, A M van Pelt, P T van der Saag, et al.
Orphanet Journal of Rare Diseases
|
June 9, 2019
Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1
M Judith Peterschmitt, Selena Freisens, Lisa H Underhill, et al.
The Journal of Biological Chemistry
|
November 21, 2000
A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells
I C Gaemers, H L Vos, H H Volders, et al.
Biochimica Et Biophysica Acta
|
January 11, 2011
Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
Ingrid C Gaemers, Jan M Stallen, Cindy Kunne, et al.
Biochimica Et Biophysica Acta
|
February 20, 2014
FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model
Cindy Kunne, Alexandra Acco, Suzanne Duijst, et al.
The FEBS Journal
|
December 5, 2006
Hepatocyte-specific interplay of transcription factors at the far-upstream enhancer of the carbamoylphosphate synthetase gene upon glucocorticoid induction
Maarten Hoogenkamp, Ingrid C Gaemers, Onard J L M Schoneveld, et al.
Clinical Pharmacology in Drug Development
|
August 28, 2020
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
M Judith Peterschmitt, Nigel P S Crawford, Sebastiaan J M Gaemers, et al.
Blood Cells, Molecules & Diseases
|
January 28, 2017
A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration
M Judith Peterschmitt, Gerald F Cox, Jennifer Ibrahim, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
Biochimie
|
April 3, 2007
cyclicAMP and glucocorticoid responsiveness of the rat carbamoylphosphate synthetase gene requires the interplay of upstream regulatory units
Onard J L M Schoneveld, Maarten Hoogenkamp, Jan M Stallen, et al.
Biochimie
|
November 6, 2012
Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
Frank G Schaap, Andreas E Kremer, Wouter H Lamers, et al.
Endocrinology
|
February 1, 1996
All-trans-4-oxo-retinoic acid: a potent inducer of in vivo proliferation of growth-arrested A spermatogonia in the vitamin A-deficient mouse testis
I C Gaemers, A M van Pelt, P T van der Saag, et al.
Orphanet Journal of Rare Diseases
|
June 9, 2019
Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1
M Judith Peterschmitt, Selena Freisens, Lisa H Underhill, et al.
The Journal of Biological Chemistry
|
November 21, 2000
A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells
I C Gaemers, H L Vos, H H Volders, et al.
Biochimica Et Biophysica Acta
|
January 11, 2011
Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
Ingrid C Gaemers, Jan M Stallen, Cindy Kunne, et al.
Biochimica Et Biophysica Acta
|
February 20, 2014
FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model
Cindy Kunne, Alexandra Acco, Suzanne Duijst, et al.
The FEBS Journal
|
December 5, 2006
Hepatocyte-specific interplay of transcription factors at the far-upstream enhancer of the carbamoylphosphate synthetase gene upon glucocorticoid induction
Maarten Hoogenkamp, Ingrid C Gaemers, Onard J L M Schoneveld, et al.
Clinical Pharmacology in Drug Development
|
August 28, 2020
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
M Judith Peterschmitt, Nigel P S Crawford, Sebastiaan J M Gaemers, et al.
Blood Cells, Molecules & Diseases
|
January 28, 2017
A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration
M Judith Peterschmitt, Gerald F Cox, Jennifer Ibrahim, et al.
Page
of 7